Global TB Diagnostic Market 2015-2019

01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Prevalence and Incidence Rate
08. Advancement in technologies
08.1.1 Second generation nucleic acid detection
08.1.2 Next generation nucleic acid detection
09. Tuberculosis Diagnostics Pipeline
10. Market Segmentation by Stage
10.1 Global TB Diagnosis Market by Latent TB
10.2 Global TB Diagnosis Market by Active TB
10.2.1 Global TB Diagnosis Market by Sputum Spear Microscopy Test
10.2.2 Global TB Diagnostic Market by Nucleic Acid Amplification Testing
10.2.3 Global TB Diagnostic Market by Culture based test
11. Geographical Segmentation
11.1 Global TB Diagnostic Market by Geographical Segmentation 2014-2019
11.2 Global TB Diagnostic Market in the APAC Region
11.2.1 India
11.3 Global TB Diagnostic Market in the Americas
11.3.1 Brazil
11.4 Global TB Diagnostic Market in the EMEA Region
11.4.1 South Africa
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and their Impact
19. Vendor Landscape
19.1 Competitive Scenario
19.1.1 Key News
19.1.2 Mergers & Acquistions
19.2 Market Share Analysis 2013
19.2.1 Abbott
19.2.2 Alere
19.2.3 Becton, Dickinson and Company
19.2.4 Hoffmann-La Roche Ltd
19.3 Other Prominent Vendors
20. Key Vendor Analysis
21.1 Abbott Diagnostics
21.1.1 Key Facts
21.1.2 Business Overview
21.1.3 Geographical Presence
21.1.4 SWOT Analysis
21.2 Alere
21.2.1 Key Facts
21.2.2 Business Overview
21.2.3 Business Segmentation by Revenue 2013
21.2.4 Business Segmentation by Revenue 2012 and 2013
21.2.5 Geographical Segmentation by Revenue 2013
21.2.6 Business Strategy
21.2.7 Recent Developments
21.2.8 SWOT Analysis
21.3 Becton, Dickinson and Co.
21.3.1 Key Facts
21.3.2 Business Description
21.3.3 Business Segmentation
21.3.4 Revenue Segmentation by Business
21.3.5 Segmental Revenue Comparison - 2013 and 2012
21.3.6 Revenue Segmentation by Geography
21.3.7 Business Strategy
21.3.8 Key Developments
21.3.9 SWOT Analysis
21.4 Roche Diagnostics
21.4.1 Key Facts
21.4.2 Business Overview
21.4.3 Business Segmentation by Revenue 2014
21.4.4 Business Segmentation by Revenue 2013 and 2014
21.4.5 Geographical Segmentation by Revenue 2014
21.4.6 Business Strategy
21.4.7 Recent Developments
21.4.8 SWOT Analysis
22. Other Reports in this Series